Elevated levels of GRP78 are characterized by low levels of chronic ERS, enabling tumor cells to activate adaptive response, which is conducive to the survival of tumor cells under adverse conditions such as chemotherapy or radiotherapy. This evidence concerns the gene HSPA5 and neoplasm.